Clinical Trials Directory

Trials / Terminated

TerminatedNCT02898623

Serological Test for the Diagnosis of TB

Performances of Immunoassays Based on the Detection of Antibodies Directed Against Mycobacterium Tuberculosis Antigen for the Diagnosis of Active Tuberculosis in Adults

Status
Terminated
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

TB remains a health problem in France with about 5,000 new cases per year. Development of new screening tests is a priority for TB. The main objective of the study is to evaluate performances of innovative blood tests to identify active tuberculosis in adults patients living in low-prevalence country. Adult patients with possible TB from will be tested for the presence of antibodies directed against M. tuberculosis selected antigens. Positive and negative predictive values will be established based on TB culture results.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionEvaluation of performance of immunoassays based on the detection of antibodies directed against Mycobacterium tuberculosis antigen

Timeline

Start date
2013-12-20
Primary completion
2014-12-20
Completion
2015-06-20
First posted
2016-09-13
Last updated
2021-12-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02898623. Inclusion in this directory is not an endorsement.